| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
*
Division of Rheumatology, Northwestern University Medical School, and
Veterans Administration Chicago Healthcare System, Lakeside Division, Chicago, IL 60611; and
Rheumatology Department, 251 Hellenic Airforce Veterans Affairs General Hospital, Athens, Greece
The regulation of proliferation and cell death is vital for homeostasis, but the mechanism that coordinately balances these events in rheumatoid arthritis (RA) remains largely unknown. In RA, the synovial lining thickens in part through increased proliferation and/or decreased synovial fibroblast cell death. Here we demonstrate that the anti-apoptotic protein, Bcl-2, is highly expressed in RA compared with osteoarthritis synovial tissues, particularly in the CD68-negative, fibroblast-like synoviocyte population. To determine the importance of endogenous Bcl-2, an adenoviral vector expressing a hammerhead ribozyme to Bcl-2 (Ad-Rbz-Bcl-2) mRNA was employed. Ad-Rbz-Bcl-2 infection resulted in reduced Bcl-2 expression and cell viability in synovial fibroblasts isolated from RA and osteoarthritis synovial tissues. In addition, Ad-Rbz-Bcl-2-induced mitochondrial permeability transition, cytochrome c release, activation of caspases 9 and 3, and DNA fragmentation. The general caspase inhibitor zVAD.fmk blocked caspase activation, poly(ADP-ribose) polymerase cleavage, and DNA fragmentation, but not loss of transmembrane potential or viability, indicating that cell death was independent of caspase activation. Ectopically expressed Bcl-xL inhibited Ad-Rbz-Bcl-2-induced mitochondrial permeability transition and apoptosis in Ad-Rbz-Bcl-2-transduced cells. Thus, forced down-regulation of Bcl-2 does not induce a compensatory mechanism to prevent loss of mitochondrial integrity and cell death in human fibroblasts.
This article has been cited by other articles:
|
|
 |
|
  E. Terzioglu, A. Bisgin, A. D. Sanlioglu, M. Ulker, V. Yazisiz, S. Tuzuner, and S. Sanlioglu Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis Rheumatology, May 1, 2007; 46(5): 783 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Albee, B. Shi, and H. Perlman Aspartic protease and caspase 3/7 activation are central for macrophage apoptosis following infection with Escherichia coli J. Leukoc. Biol., January 1, 2007; 81(1): 229 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-S. Lee, S.-A. Yoo, C.-S. Cho, P.-G. Suh, W.-U. Kim, and S. H. Ryu Serum Amyloid A Binding to Formyl Peptide Receptor-Like 1 Induces Synovial Hyperplasia and Angiogenesis J. Immunol., October 15, 2006; 177(8): 5585 - 5594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Kitagawa, Y Miura, R Saura, M Mitani, H Ishikawa, A Hashiramoto, S Yoshiya, S Shiozawa, and M Kurosaka Anchorage on fibronectin via VLA-5 ({alpha}5{beta}1 integrin) protects rheumatoid synovial cells from Fas-induced apoptosis Ann Rheum Dis, June 1, 2006; 65(6): 721 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Liu, P. Eksarko, V. Temkin, G. K. Haines III, H. Perlman, A. E. Koch, B. Thimmapaya, and R. M. Pope Mcl-1 Is Essential for the Survival of Synovial Fibroblasts in Rheumatoid Arthritis J. Immunol., December 15, 2005; 175(12): 8337 - 8345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hutcheson, J. C. Scatizzi, E. Bickel, N. J. Brown, P. Bouillet, A. Strasser, and H. Perlman Combined loss of proapoptotic genes Bak or Bax with Bim synergizes to cause defects in hematopoiesis and in thymocyte apoptosis J. Exp. Med., June 20, 2005; 201(12): 1949 - 1960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Drynda, P. H. A. Quax, M. Neumann, W. H. van der Laan, G. Pap, S. Drynda, I. Meinecke, J. Kekow, W. Neumann, T. W. J. Huizinga, et al. Gene Transfer of Tissue Inhibitor of Metalloproteinases-3 Reverses the Inhibitory Effects of TNF-{alpha} on Fas-Induced Apoptosis in Rheumatoid Arthritis Synovial Fibroblasts J. Immunol., May 15, 2005; 174(10): 6524 - 6531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Brown, J. Hutcheson, E. Bickel, J. C. Scatizzi, L. D. Albee, G. K. Haines III, J. Eslick, K. Bradley, E. Taricone, and H. Perlman Fas Death Receptor Signaling Represses Monocyte Numbers and Macrophage Activation In Vivo J. Immunol., December 15, 2004; 173(12): 7584 - 7593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Kawakami, S Urayama, S Yamasaki, A Hida, T Miyashita, M Kamachi, K Nakashima, F Tanaka, H Ida, Y Kawabe, et al. Anti-apoptogenic function of TGF{beta}1 for human synovial cells: TGF{beta}1 protects cultured synovial cells from mitochondrial perturbation induced by several apoptogenic stimuli Ann Rheum Dis, January 1, 2004; 63(1): 95 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Liu, Y. Ma, S. M. Cole, C. Zander, K.-H. Chen, J. Karras, and R. M. Pope Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival Blood, July 1, 2003; 102(1): 344 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Perlman, K. Bradley, H. Liu, S. Cole, E. Shamiyeh, R. C. Smith, K. Walsh, S. Fiore, A. E. Koch, G. S. Firestein, et al. IL-6 and Matrix Metalloproteinase-1 Are Regulated by the Cyclin-Dependent Kinase Inhibitor p21 in Synovial Fibroblasts J. Immunol., January 15, 2003; 170(2): 838 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Liu, H. Perlman, L. J. Pagliari, and R. M. Pope Constitutively Activated Akt-1 Is Vital for the Survival of Human Monocyte-differentiated Macrophages: Role of Mcl-1, Independent of Nuclear Factor (NF)-{kappa}B, Bad, or Caspase Activation J. Exp. Med., July 9, 2001; 194(2): 113 - 126. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
